Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Andrae

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Lakartidningen|July 16, 2013
[Does screening for HPV solve more problems than it creates?]Björn Strander, Bengt Andrae
Lakartidningen|December 13, 2006
[Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]Joakim Dillner, Bengt Andrae, Bengt Westermark
Lakartidningen|July 3, 2002
[HPV testing--the effect must be evaluated prior to clinical use!]Elisabeth Persson, Bengt Andrae, Björn Strander
Lakartidningen|April 3, 2008
[Organized improvement of cervix cancer prevention]Bengt Andrae, Kristina Elfgren, Björn Strander
Acta Obstetricia Et Gynecologica Scandinavica|August 20, 2009
Value of high-risk HPV-DNA testing in the triage of ASCUSIréne Silverloo, Bengt Andrae, Erik Wilander
Lakartidningen|July 13, 2011
[New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears]Björn Strander, Kristina Elfgren, Bengt Andrae
Lakartidningen|June 6, 2018
[Cervical cancer has increased in Sweden in women who had a normal cell sample]Joakim Dillner, Pär Sparén, Bengt Andrae, et al.
Lakartidningen|February 28, 2018
Joakim Dillner, Bengt Andrae, Björn Strander, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2020
Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort studyJiangrong Wang, Bengt Andrae, Björn Strander, et al.
Acta Cytologica|June 2, 2021
Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical CancerHenrik Edvardsson, Jiangrong Wang, Bengt Andrae, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Lakartidningen|July 16, 2013
[Does screening for HPV solve more problems than it creates?]Björn Strander, Bengt Andrae
Lakartidningen|December 13, 2006
[Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]Joakim Dillner, Bengt Andrae, Bengt Westermark
Lakartidningen|July 3, 2002
[HPV testing--the effect must be evaluated prior to clinical use!]Elisabeth Persson, Bengt Andrae, Björn Strander
Lakartidningen|April 3, 2008
[Organized improvement of cervix cancer prevention]Bengt Andrae, Kristina Elfgren, Björn Strander
Acta Obstetricia Et Gynecologica Scandinavica|August 20, 2009
Value of high-risk HPV-DNA testing in the triage of ASCUSIréne Silverloo, Bengt Andrae, Erik Wilander
Lakartidningen|July 13, 2011
[New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears]Björn Strander, Kristina Elfgren, Bengt Andrae
Lakartidningen|June 6, 2018
[Cervical cancer has increased in Sweden in women who had a normal cell sample]Joakim Dillner, Pär Sparén, Bengt Andrae, et al.
Lakartidningen|February 28, 2018
Joakim Dillner, Bengt Andrae, Björn Strander, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2020
Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort studyJiangrong Wang, Bengt Andrae, Björn Strander, et al.
Acta Cytologica|June 2, 2021
Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical CancerHenrik Edvardsson, Jiangrong Wang, Bengt Andrae, et al.
Pageof 3